InspireMD has appointed Dr Peter A. Soukas as Chief Medical Officer to enhance its clinical and medical organization. His expertise will guide the company in launching the CGuard Prime stent platform in the U.S
Who to call at InspireMD, and when
A new leader at InspireMD brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day InspireMD raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at InspireMD, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
InspireMD
Location
6303 WATERFORD DISTRICT DRIVE
Miami, Florida, United States
About
InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise—delivering smart design for stroke prevention through our proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prolapse and provide exceptional neurovascular protection during and after carotid procedures.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment InspireMD changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.